{"id":426,"date":"2014-07-29T12:16:01","date_gmt":"2014-07-29T12:16:01","guid":{"rendered":"https:\/\/blogs.bmj.com\/jnnp\/?p=426"},"modified":"2014-07-29T12:16:52","modified_gmt":"2014-07-29T12:16:52","slug":"ms-and-pregnancy-control-the-disease-before-for-good-outcomes","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jnnp\/2014\/07\/29\/ms-and-pregnancy-control-the-disease-before-for-good-outcomes\/","title":{"rendered":"MS and Pregnancy: Control the disease before conception for good outcomes?"},"content":{"rendered":"

Pregnancy has been traditionally associated with lower frequency of relapses and more quiescent MS disease activity.\u00a0 Consequently, cessation of medications is encouraged, and is necessary for some of the newer oral therapies.\u00a0 In this issue of JNNP the Italisn MS group publish an important and elegant paper documenting that the control of disease post-partum is really dependent on what is occurring pre conception.\u00a0 Fewer relapses before pregnancy and lower disability score 9perhpas reflecting less active disease) is associated with better outcomes, as is early resumption of disease modifying agents.<\/p>\n

 <\/p>\n

Read more at http:\/\/jnnp.bmj.com\/content\/85\/8\/845.abstract<\/p>\n

 <\/p>\n

J Neurol Neurosurg Psychiatry<\/abbr> <\/span> 2014;<\/span>85:<\/span><\/span>845-850 <\/span> doi:10.1136\/jnnp-2013-306054 <\/span> <\/cite><\/div>\n